Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Lymphoma, Large B-Cell, Diffuse 22Breast Neoplasms 19Lymphoma 14Sarcoma 13Lymphoma, Non-Hodgkin 9Lymphoma, Follicular 8Lymphoma, B-Cell 8Hodgkin Disease 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Mantle-Cell 5Immunoblastic Lymphadenopathy 5Ovarian Neoplasms 4Neoplasms 4Lymphoma, T-Cell, Peripheral 4Lymphoma, Large-Cell, Anaplastic 4Leukemia, Lymphocytic, Chronic, B-Cell 4Carcinoma, Hepatocellular 4Recurrence 3Neoplasm Metastasis 3Multiple Myeloma 3Lymphoma, Primary Effusion 3Chondrosarcoma 3Triple Negative Breast Neoplasms 2Solitary Fibrous Tumors 2Sarcoma, Clear Cell 2Plasmablastic Lymphoma 2Osteosarcoma 2Lymphoma, T-Cell 2Lymphoma, B-Cell, Marginal Zone 2Liver Neoplasms 2

Interventions

Cisplatin 2tislelizumab 1surufatinib 1spartalizumab 1sapanisertib 1pegfilgrastim 1fosbretabulin 1efatutazone 1crolibulin 1Radiotherapy 1Paclitaxel 1Filgrastim 1Doxorubicin 1CCT239065 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Thyroid Carcinoma, Anaplastic × Doxorubicin × Clear all
NCT00077103 2010-06-11

Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer

Case Comprehensive Cancer Center

Phase 1/2 Terminated
4 enrolled
EndocrineHead & Neck

Head and Neck Neoplasms, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡